Safety and Performance Study of the Siello S Pacing Lead

NCT01791127 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1758

Last updated 2020-06-01

Study results available
· View outcomes & findings →

Summary

The objective of the SIELLO study is to demonstrate the safety and effectiveness of the BIOTRONIK Siello S pacing lead.

Conditions

  • Safety and Effectiveness of the Siello S Lead

Interventions

DEVICE

market-released BIOTRONIK pacemaker system including one or two Siello S leads.

Sponsors & Collaborators

  • Biotronik, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-13
Primary Completion
2019-04-17
Completion
2019-04-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01791127 on ClinicalTrials.gov